RAD51 and oral cavity squamous cell carcinoma: Furthermore, in additional cancers such as oral squamous cell carcinoma and hepatocellular carcinoma, palbociclib significantly inhibits cellular growth, accelerates senescence and apoptosis, and suppresses RAD51 foci formation (59, 60).